The PAX5‐JAK2+ B‐ALLs belong to the Philadelphia chromosome‐like (Ph‐like) ALL subgroup, which is characterized by genetic alterations leading to constitutive activation of kinase signaling (Roberts et al, 2012, 2014). The gene discussed is JAK2; the disease is acute lymphoblastic leukemia.